Losartan Hydrochlorothiazide Tablets Market: How Is Fixed-Dose Combination Therapy Becoming the Fastest-Growing Hypertension Management Segment?
Fixed-dose combination (FDC) losartan-hydrochlorothiazide tablets — the once-daily oral antihypertensive pairing an angiotensin II receptor blocker with a thiazide diuretic for synergistic blood pressure reduction and improved patient adherence — represent the fastest-growing formulation segment in the global ARB combination market, with the Losartan Hydrochlorothiazide Tablets...
0 Comments 0 Shares 195 Views 0 Reviews